Clinical improvement of psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 1, 2006, Pages 74-75

  De Socio, Giuseppe Vittorio Luigi ^a   Simonetti, Stefano ^a   Stagni, Giuliano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; ANTIRETROVIRUS AGENT; ENFUVIRTIDE; STAVUDINE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; LYMPHOCYTE COUNT; MALE; PSORIASIS VULGARIS; SIDE EFFECT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HUMANS; MALE; MIDDLE AGED; PSORIASIS;

EID: 31144469236     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500322296     Document Type: Article

References (13)

1. Kirby, B and Griffiths, CE. (2002) Novel immune-based therapies for psoriasis Br J Dermatol, 146, pp. 546-51.
2. Mallon, E. (2000) Retroviruses and psoriasis Curr Opin Infect Dis, 13, pp. 103-7.
3. Mallon, E and Young, D and Bunce, M and (1998) HLA-Cw*0602 and HIV-associated psoriasis Br J Dermatol, 139, pp. 527-33.
4. Moles, JP and Hadi, JC and Guilhou, JJ. (2003) High prevalence of an IgG response against murine leukaemia virus (MLV) in patients with psoriasis Virus Res, 94, pp. 97-101.
5. Sugiyama, H and Gyulai, R and Toichi, E and Shimada, S and (2005) Dysfunctional blood and target tissue CD4+CD25 high regulatory T-cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T-cell proliferation J Immunol, 174, pp. 164-73.
6. Weiss, L and Donkova-Petrini, V and Caccavelli, L and Balbo, M and Carbonneil, C and Levy, Y. (2004) Human immunodeficiency virus-driven expansion of CD4+CD25+ Regulatory T-cells which suppress HIV-specific CD4 T-cell responses in HIV-infected patients Blood, 104, pp. 3249-56.
7. Barretina, J and Blanco, J and Bonjoch, A and Llano, A and Clotet, B and Este, JA. (2004) Immunological and virological study of enfuvirtide-treated HIV-positive patients AIDS, 18, pp. 1673-82.
8. Robert, C and Kupper, TS. (1999) Inflammatory skin diseases, T-cells, and immune surveillance N Engl J Med, 341, pp. 1817-28.
9. Gudjonsson, JE and Johnston, A and Sigmundsdottir, H and Valdimarsson, H. (2004) Immunopathogenic mechanisms in psoriasis Clin Exp Immunol, 135, pp. 1-8.
10. Ketas, TJ and Frank, I and Klasse, PJ and Sullivan, BM and Gardner, JP and Spenlehauer, C and (2003) Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and transinfection of primary cells J Virol, 77, pp. 2762-7.
11. Schon, MP and Boehncke, WH. (2005) Psoriasis N Engl J Med, 352, pp. 1899-1912.
12. Leonardi, CL and Powers, JL and Matheson, RT and (2003) Etanercept as monotherapy in patients with psoriasis N Engl J Med, 349, pp. 2014-22.
13. Kedzierska, K and Crowe, SM. (2001) Cytokines and HIV-1: Interactions and clinical implications Antivir Chem Chemother, 12, pp. 133-50.